Showing results (11-20 of 299) with videos related to
Sort By:
Pageof 30
The Oncologist|August 22, 2018
Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective StudyLijia Xie, Seema Nagpal, Heather A Wakelee, et al.American Journal of Ophthalmology|July 20, 2015
Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer TherapyLoh-Shan B Leung, Joel W Neal, Heather A Wakelee, et al.Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Pemetrexed in patients with thymic malignancies previously treated with chemotherapyYing Liang, Sukhmani K Padda, Jonathan W Riess, et al.Lung Cancer (Amsterdam, Netherlands)|July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interactionMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.Anticancer Research|February 11, 2015
GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarrayJonathan W Riess, Robert West, Michelle Dean, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2021
Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLCJessica A Hellyer, Jacqueline V Aredo, Millie Das, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 8, 2017
ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted TherapiesJody C Chuang, Henning Stehr, Ying Liang, et al.Clinical Lung Cancer|November 17, 2018
Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung CancerNathaniel J Myall, Solomon Henry, Douglas Wood, et al.Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancerJessica A Hellyer, Henning Stehr, Millie Das, et al.Clinical Lung Cancer|February 15, 2014
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment eraJonathan W Riess, Seema Nagpal, Michael Iv, et al.Pageof 30